WHITEPAPER

Case study: revolutionizing cancer treatment in personalized vaccine development

Case study demonstrating how myNEO's ImmunoEngine neoantigen discovery pipeline supports personalized cancer vaccine development through comprehensive neoantigen discovery.

Your browser does not support embedded PDFs. Open the PDF directly →

For the best reading experience on mobile, open the PDF in a new tab.